0 230

Cited 0 times in

Cited 0 times in

Outcomes by primary tumour location in patients with advanced biliary tract cancer treated with durvalumab or placebo plus gemcitabine and cisplatin in the phase 3 TOPAZ-1 study

DC Field Value Language
dc.date.accessioned2023-06-02T01:04:12Z-
dc.date.available2023-06-02T01:04:12Z-
dc.date.issued2022-06-
dc.identifier.issn0923-7534-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/194629-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherOxford University Press-
dc.relation.isPartOfANNALS OF ONCOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleOutcomes by primary tumour location in patients with advanced biliary tract cancer treated with durvalumab or placebo plus gemcitabine and cisplatin in the phase 3 TOPAZ-1 study-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorA. He-
dc.contributor.googleauthorJ. Valle-
dc.contributor.googleauthorC. Lee-
dc.contributor.googleauthorM. Ikeda-
dc.contributor.googleauthorP. Potemski-
dc.contributor.googleauthorC. Morizane-
dc.contributor.googleauthorJ. Cundom-
dc.contributor.googleauthorD. Tougeron-
dc.contributor.googleauthorF. Dayyani-
dc.contributor.googleauthorN. Rokutanda-
dc.contributor.googleauthorJ. Xiong-
dc.contributor.googleauthorG. Cohen-
dc.contributor.googleauthorD. Oh-
dc.identifier.doi10.1016/j.annonc.2022.04.442-
dc.relation.journalcodeJ00171-
dc.identifier.eissn1569-8041-
dc.identifier.urlhttps://www.sciencedirect.com/science/article/pii/S0923753422011322-
dc.citation.volume33-
dc.citation.numberSuppl 4-
dc.citation.startPageS378-
dc.identifier.bibliographicCitationANNALS OF ONCOLOGY, Vol.33(Suppl 4) : S378, 2022-06-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.